J&J study suggests earlier use of prostate cancer drug improves outcomes

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...
Healio

‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Ep 1 - Too Much Medicine

Barry Stevenson and his wife Billy started skating about five years ago - just before Barry was diagnosed with prostate cancer. He faced the possibility of being one of the two and a half thousand ...
The Manila Times

Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...
The New England Journal of Medicine

Perioperative Apalutamide in High-Risk Localized Prostate Cancer

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...